Back to search results

Research Associates in Cancer Drug Discovery (2 Posts Available)

The University of Manchester

Location: Manchester
Salary: £33,309 to £36,382 per annum dependent on experience
Hours: Full Time
Contract Type: Fixed-Term/Contract
Placed On: 14th September 2021
Closes: 11th October 2021
Job Ref: BMH-017453

Job reference: BMH-017453

Location: Oxford Road, Manchester

Closing date (DD/MM/YYYY): 11/10/2021

Salary: £33,309 - £36,382 per annum dependent on experience

Employment type: Fixed Term

Faculty/Organisation: Biology, Medicine & Health

School/ Directorate: Cancer Sciences

Hours per week: Full Time

Contract Duration: 03 January 2022 until 02 July 2023

Applications are invited for a Research Associate in Cancer Drug Discovery within the Pharmaceutical Sciences group at the University of Manchester. The post is available from the 3rd Jan 2022 and will be tenable on a fixed term basis for 18 months, with the potential to extend.

You will contribute to a multi-disciplinary MRC DPFS funded project, focusing on the investigating a novel class of protein drug conjugates as potential therapies for Chronic myelomonocytic leukaemia (CMML). You should be able to interact effectively with researchers from a range of other disciplines to contribute to the programme of research.

You should hold a PhD in Pharmacology, Physiology, Pharmacy, Biology or Medicine or equivalent and have experience in studies using preclinical tumour disease models.

The candidate would ideally hold an active Home Office Animals (Scientific Procedures) Act 1986 Personal Licence. A basic understanding of cancer biology will be necessary, and evidence of a developing research publication track record would be advantageous.

“Successful candidates may be subject to pre-employment screening carried out on our behalf by a third party. The offer of employment will be dependent on the successful candidate passing that screening. Whilst you will be required to provide express consent at a later stage, by continuing with your application now you acknowledge that you are aware that such screening will take place, and agree to take part in the process.”

As this role involves research at a postgraduate level, applicants who are not an EEA national or a national of an exempt country and who will require sponsorship under the Skilled Worker route of the UK Visas and Immigration’s (UKVI) Points Based System in order to take up the role, will be required to apply for an Academic Technology Approval Scheme (ATAS) Certificate and will need to obtain this prior to making any official visa application UKVI)

The School is strongly committed to promoting equality and diversity, including the Athena SWAN charter for gender equality in higher education. The School holds a Silver Award which recognises their good practice in relation to gender; including flexible working arrangements, family-friendly policies, and support to allow staff achieve a good work-life balance. We particularly welcome applications from women for this post. All appointment will be made on merit. For further information, please visit: 

Our University is positive about flexible working – you can find out more here

Blended working arrangements may be considered

Please note that we are unable to respond to enquiries, accept CVs or applications from Recruitment Agencies.

Enquiries about the vacancy, shortlisting and interviews:

Name: Kiran Batta


Name: Dan Wiseman


Name: Sam Butterworth


General enquiries:


Technical support:

This vacancy will close for applications at midnight on the closing date.

We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role:

Subject Area(s):


Job tools
More jobs from The University of Manchester

Show all jobs for this employer …

More jobs like this
Join in and follow us

Browser Upgrade Recommended has been optimised for the latest browsers.

For the best user experience, we recommend viewing on one of the following:

Google Chrome Firefox Microsoft Edge